Neurocrine Biosciences, Inc. (BIT:1NBIX)
Italy · Delayed Price · Currency is EUR 122.40
0.00 (0.00%)
At close: Dec 29, 2025
Neurocrine Biosciences Market Cap
Neurocrine Biosciences has a market cap or net worth of €12.04 billion as of January 2, 2026. Its market cap has decreased by -1.45% in one year.
Market Cap
12.04B
Enterprise Value
11.50B
Revenue
2.29B
Ranking
n/a
PE Ratio
33.02
Stock Price
€122.40
Market Cap Chart
Since May 23, 1996, Neurocrine Biosciences's market cap has increased from 167.33M to 12.04B, an increase of 7,097.70%. That is a compound annual growth rate of 15.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 12.04B | -9.77% |
| Dec 31, 2024 | 13.35B | 13.98% |
| Dec 29, 2023 | 11.71B | 9.01% |
| Dec 30, 2022 | 10.74B | 51.23% |
| Dec 31, 2021 | 7.10B | -2.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UniCredit | 110.47B |
| Intesa Sanpaolo | 102.93B |
| Enel SpA | 88.80B |
| Ferrari | 56.53B |
| Assicurazioni Generali | 54.29B |
| Eni S.p.A. | 48.95B |
| Leonardo S.p.a. | 28.34B |
| Banca Monte dei Paschi di Siena | 27.74B |